{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-050541","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-11-06T22:28:31+00:00","discovered_at":"2026-11-06T22:30:00.365104+00:00","generated_at":"2026-11-06T22:30:08.038968+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"bioAffinity Q3 revenue falls to $1.1M; net loss widens to $5.3M despite CyPath unit sales doubling","bullets":["Q3 2026 total revenue was ~$1.1M vs ~$1.4M a year ago; CyPath Lung testing revenue for the first nine months rose 79% to ~$1.1M.","Net loss was ~$5.3M vs ~$5.1M in Q3 2025; operating loss widened to ~$3.5M from ~$2.3M, with operating expenses ~$4.6M vs ~$3.7M.","CyPath Lung unit sales rose 100% through Q3 vs the first nine months of 2025; ordering physicians increased 89% YoY and existing-physician volume rose 48%.","Cash was ~$2.6M at Sept. 30 vs ~$6.4M at Dec. 31, 2025; the company raised $8.0M gross in August and October 2026 offerings, including ~$4.0M after quarter-end.","Signed an AvMEDICAL distribution agreement targeting VA/government channels; 11 clinical trial sites are active, including nine VA/military centers; patent portfolio has 22 awarded and 36 pending."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-050541","json":"https://secwatch.observer/filing/0001493152-26-050541.json","markdown":"https://secwatch.observer/filing/0001493152-26-050541.md","text":"https://secwatch.observer/filing/0001493152-26-050541.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226050541/0001493152-26-050541-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226050541/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-06T22:30:08.038968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}